vs
Side-by-side financial comparison of Primis Financial Corp. (FRST) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
Primis Financial Corp. is the larger business by last-quarter revenue ($45.6M vs $32.6M, roughly 1.4× RxSight, Inc.). Primis Financial Corp. runs the higher net margin — 16.0% vs -28.1%, a 44.1% gap on every dollar of revenue. Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs 5.1%).
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
FRST vs RXST — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $45.6M | $32.6M |
| Net Profit | $7.3M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | — | -34.8% |
| Net Margin | 16.0% | -28.1% |
| Revenue YoY | — | -18.9% |
| Net Profit YoY | 200.0% | -54.1% |
| EPS (diluted) | $0.30 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $32.6M | ||
| Q3 25 | $41.0M | $30.3M | ||
| Q2 25 | $43.2M | $33.6M | ||
| Q1 25 | $58.7M | $37.9M | ||
| Q4 24 | $38.8M | $40.2M | ||
| Q3 24 | $37.3M | $35.3M | ||
| Q2 24 | $35.7M | $34.9M |
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | $-9.2M | ||
| Q3 25 | $6.8M | $-9.8M | ||
| Q2 25 | $2.4M | $-11.8M | ||
| Q1 25 | $22.6M | $-8.2M | ||
| Q4 24 | $-26.2M | $-5.9M | ||
| Q3 24 | $1.2M | $-6.3M | ||
| Q2 24 | $3.4M | $-6.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% |
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | -34.8% | ||
| Q3 25 | 21.3% | -40.1% | ||
| Q2 25 | 6.9% | -41.6% | ||
| Q1 25 | 41.9% | -28.2% | ||
| Q4 24 | -123.0% | -21.5% | ||
| Q3 24 | -3.1% | -26.1% | ||
| Q2 24 | 7.8% | -23.9% |
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | -28.1% | ||
| Q3 25 | 16.7% | -32.4% | ||
| Q2 25 | 5.6% | -35.0% | ||
| Q1 25 | 38.6% | -21.6% | ||
| Q4 24 | -100.3% | -14.8% | ||
| Q3 24 | 3.3% | -17.9% | ||
| Q2 24 | 9.6% | -17.4% |
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $-0.22 | ||
| Q3 25 | $0.28 | $-0.24 | ||
| Q2 25 | $0.10 | $-0.29 | ||
| Q1 25 | $0.92 | $-0.20 | ||
| Q4 24 | $-0.95 | $-0.14 | ||
| Q3 24 | $0.05 | $-0.16 | ||
| Q2 24 | $0.14 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.9M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $427.2M | $275.7M |
| Total Assets | $4.3B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $228.1M | ||
| Q3 25 | $63.9M | $227.5M | ||
| Q2 25 | $94.1M | $227.5M | ||
| Q1 25 | $57.0M | $229.3M | ||
| Q4 24 | $64.5M | $237.2M | ||
| Q3 24 | $77.3M | $237.1M | ||
| Q2 24 | $66.6M | $233.3M |
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $275.7M | ||
| Q3 25 | $382.2M | $276.0M | ||
| Q2 25 | $376.4M | $278.0M | ||
| Q1 25 | $375.6M | $279.3M | ||
| Q4 24 | $351.8M | $281.2M | ||
| Q3 24 | $381.0M | $277.3M | ||
| Q2 24 | $376.0M | $275.2M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $311.8M | ||
| Q3 25 | $4.0B | $308.5M | ||
| Q2 25 | $3.9B | $309.0M | ||
| Q1 25 | $3.7B | $313.0M | ||
| Q4 24 | $3.7B | $318.6M | ||
| Q3 24 | $4.0B | $310.5M | ||
| Q2 24 | $4.0B | $305.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-1.1M |
| Free Cash FlowOCF − Capex | — | $-2.3M |
| FCF MarginFCF / Revenue | — | -6.9% |
| Capex IntensityCapex / Revenue | — | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $-1.1M | ||
| Q3 25 | $-11.4M | $-1.2M | ||
| Q2 25 | $-41.0M | $-4.4M | ||
| Q1 25 | $34.4M | $-8.8M | ||
| Q4 24 | $19.5M | $-4.3M | ||
| Q3 24 | $6.1M | $650.0K | ||
| Q2 24 | $52.3M | $-4.0M |
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | $-2.3M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | — | $-5.9M | ||
| Q1 25 | — | $-9.4M | ||
| Q4 24 | $18.3M | $-5.1M | ||
| Q3 24 | — | $-453.0K | ||
| Q2 24 | — | $-5.5M |
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | -6.9% | ||
| Q3 25 | — | -5.8% | ||
| Q2 25 | — | -17.6% | ||
| Q1 25 | — | -24.8% | ||
| Q4 24 | 47.3% | -12.7% | ||
| Q3 24 | — | -1.3% | ||
| Q2 24 | — | -15.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 3.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | 3.1% | 2.1% | ||
| Q3 24 | 0.0% | 3.1% | ||
| Q2 24 | 0.0% | 4.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | — | ||
| Q3 25 | -1.67× | — | ||
| Q2 25 | -16.82× | — | ||
| Q1 25 | 1.52× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.93× | — | ||
| Q2 24 | 15.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
